Back to Search Start Over

P926: DARATUMUMAB, BORTEZOMIB AND DEXAMETHASONE FOR TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND SEVERE RENAL IMPAIRMENT: RESULTS FROM THE PHASE 2 GMMG-DANTE TRIAL

Authors :
L. Leypoldt
M. Gavriatopoulou
B. Besemer
H. Salwender
M.-S. Raab
A. Nogai
C. Khandanpour
V. Runde
M. Zago
P. Martus
H. Goldschmidt
C. Bokemeyer
M. Dimopoulos
K. Weisel
Source :
HemaSphere, Vol 6, Pp 816-817 (2022)
Publication Year :
2022
Publisher :
Wiley, 2022.

Subjects

Subjects :
Diseases of the blood and blood-forming organs
RC633-647.5

Details

Language :
English
ISSN :
25729241
Volume :
6
Database :
Directory of Open Access Journals
Journal :
HemaSphere
Publication Type :
Academic Journal
Accession number :
edsdoj.332a256d47644c7a9893f14daac86237
Document Type :
article
Full Text :
https://doi.org/10.1097/01.HS9.0000846572.66058.38
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details